The ingredient, standardized to thymoquinone and low free fatty acid content, is classified as a novel food to be sold in dietary supplements in the country.
Shortly after the approval of the HMOs 2’-FL and LNnT, global suppliers dsm-firmenich and IFF were among the first companies to receive individual clearance.